Dose-Escalation of Botulinum Toxin in Subjects With Osteoarthritis of the Knee

NCT02139319 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Knee Osteoarthritis

Interventions

DRUG: Botulinum toxin
DRUG: Placebo

Sponsor

Galderma R&D